Skip to content

A Study to Evaluate Sampling Methods for Subgingival Plaque

A Pilot Study to Evaluate Sampling Methods for Subgingival Plaque

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02841839
Enrollment
20
Registered
2016-07-22
Start date
2016-06-30
Completion date
2016-06-30
Last updated
2023-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subgingival Plaque

Brief summary

To identify a sampling method for collecting subgingival plaque

Interventions

DRUGStannous Fluoride

Sponsors

Procter and Gamble
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Provide written informed consent to participate in the study; * Be 18 years of age or older; * Agree not to participate in any other oral/dental product studies during the course of this study; * Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed; * Agree to use the acclimation toothpaste together with their regular brush and refrain from any other oral care products (including floss and mouth rinse) between the Screening and Baseline Visit; * Agree to use the treatment products and refrain from any form of non-specified oral hygiene during the treatment periods (after the Baseline Visit), including but not limited to the use of products such as floss, mouth rinse, or whitening products; * Agree to return for all scheduled visits and follow study procedures; * Must have at least 16 natural teeth; * Be in good general health, as determined by the Investigator/designee based on a review of the health history/update for participation in the study; * Agree to refrain from all oral hygiene for at least 12 hours prior to each visit; * Agree to refrain from eating, chewing gum, drinking and using tobacco for 4 hours prior to each visit; * Have 10-20 bleeding sites; and * Have minimum 6 sampling sites with bleeding and pocket depth ≥2mm but not deeper than 4mm.

Exclusion criteria

* Have had a dental prophylaxis within 2 weeks of plaque sampling visits; * Have taken antibiotics or used anti-gingivitis / anti-bacterial oral care products such as chlorhexidine or Listerine within 2 weeks of plaque sampling visits; * Have rampant caries, open or untreated caries, or advanced periodontitis requiring prompt treatment; * Taking allergy medication or any other medication that can affect salivary flow such as an antihistamine; * Need an antibiotic prophylaxis prior to dental visits; * A history of hypersensitivity to oral care products containing hydrogen peroxide or stannous fluoride; * A history of hypersensitivity to products containing sodium lauryl sulfate (SLS); * Are pregnant (Self-reported) or lactating; or * Have any condition or disease, as determined by the Investigator/Designee based on a review of the medical history, which could be expected to interfere with examination procedures or with the subject's safe completion of the study.

Design outcomes

Primary

MeasureTime frameDescription
Subgingival plaque4 weekssubgingival plaque quantity measured by periopaper or curette sampling

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026